Skip to main content
Log in

Prognostic role of diuretic failure in determining mortality for patients hospitalized with acute decompensated heart failure

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Background

Worsening heart failure (WHF) is defined as persistent or worsening symptoms of heart failure that require an escalation in intravenous therapy or initiation of mechanical and ventilatory support during hospitalization. We assessed a simplified version of WHF called diuretic failure (DF), defined as an escalation of loop diuretic dosing after 48 h, and assessed its effects on mortality and rehospitalizations at 60-days.

Methods

We conducted a multicenter retrospective study between December 1, 2017 and January 1, 2020. We identified 1389 patients of which 6.4% experienced DF.

Results

There was a significant relationship between DF and cumulative rates of 60-day mortality and 60-day rehospitalizations (p = 0.0002 and p = 0.0214). After multivariate adjustment, DF was associated with longer hospital stay (p < 0.0001), increased rate of 60-day mortality (p = 0.026), 60-day rehospitalizations (p = 0.036), and a composite outcome of 60-day mortality and 60-day cardiac rehospitalizations (p = 0.018).

Conclusions

DF has a strong relationship with adverse heart failure outcomes suggesting it is a simple yet robust prognostic indicator which can be used in real time to identify high-risk patients during hospitalization and beyond.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Akintoye E, Briasoulis A, Egbe A, Dunlay SM, Kushwaha S, Levine D, Afonso L, Mozaffarian D, Weinberger J (2017) National trends in admission and in-hospital mortality of patients with heart failure in the united states (2001–2014). J Am Heart Assoc 6(12):e006955

    Article  Google Scholar 

  2. Tang WHW, Grodin JL (2015) Worsening heart failure: challenges as a therapeutic target. JACC Heart Fail 3:404–407

    Article  Google Scholar 

  3. Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O’Connor CM (2010) Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure–association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology 115:29–36

    Article  Google Scholar 

  4. Mentz RJ, Metra M, Cotter G, Milo O, McKendry C, Chiswell K, Davison BA, Cleland JG, Bloomfield DM, Dittrich HC, Fiuzat M, Ponikowski P, Givertz MM, Voors AA, Teerlink JR, O’Connor CM (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. Eur J Heart Fail 17:697–706

    Article  Google Scholar 

  5. Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T (2013) REVIVE heart failure study group. effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 1:103–111

    Article  Google Scholar 

  6. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM (2013) NHLBI heart failure clinical research network low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the rose acute heart failure randomized trial. JAMA 310:2533–43

    Article  CAS  Google Scholar 

  7. Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, Investigators PROTECT, Committees, (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419–1428

    Article  Google Scholar 

  8. McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I, Investigators VERITAS (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298:2009–2019

    Article  CAS  Google Scholar 

  9. Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M (2013) RELAXin in acute heart failure (RELAX-AHF) investigators serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29–39

    Article  CAS  Google Scholar 

  10. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) NHLBI heart failure clinical research network diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805

    Article  CAS  Google Scholar 

  11. Weatherley BD, Milo-Cotter O, Felker GM, Uriel N, Kaluski E, Vered Z, O’Connor CM, Adams KF, Cotter G (2009) Early worsening heart failure in patients admitted with acute heart failure–a new outcome measure associated with long-term prognosis? Fundam Clin Pharmacol 23:633–639

    Article  CAS  Google Scholar 

  12. Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G (2009) Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome. J Card Fail 15:639–644

    Article  Google Scholar 

  13. Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR, Investigators VERITAS (2014) Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail 16:1362–1371

    Article  Google Scholar 

  14. Čerlinskaitė K, Javanainen T, Cinotti R, Mebazaa A (2018) Global research on acute conditions team (GREAT) network acute heart failure management. Korean Circ J 48:463–480

    Article  Google Scholar 

  15. Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293

    Article  CAS  Google Scholar 

  16. Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7:261–270

    Article  CAS  Google Scholar 

  17. Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, Kirkpatrick JN (2010) Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105:511–516

    Article  Google Scholar 

  18. Tabucanon T, Tang WHW (2020) Right heart failure and cardiorenal syndrome. Cardiol Clin 38:185–202

    Article  Google Scholar 

  19. Teerlink JR, Alburikan K, Metra M, Rodgers JE (2015) Acute decompensated heart failure update. Curr Cardiol Rev 11:53–62

    Article  Google Scholar 

  20. Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E (1993) Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 22(4):968–974

    Article  CAS  Google Scholar 

Download references

Funding

This research received no grant or financial support from any funding agency.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: SM, MPF, M S, AS, JM, AR, MNV; Methodology: SM, MPF, MS, AS; Formal analysis and investigation: MPF, MS, AS; Writing-original draft preparation: SM; Writing-review and editing: SM, MPF, MS, ASh, JM, AR, MNV; Resources: MNV; Supervision: MNV.

Corresponding author

Correspondence to Salmaan Mumtaz.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of WellSpan York Hospital who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of WellSpan York Hospital.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mumtaz, S., Sharma, M., Fu, M.P. et al. Prognostic role of diuretic failure in determining mortality for patients hospitalized with acute decompensated heart failure. Heart Vessels 37, 1373–1379 (2022). https://doi.org/10.1007/s00380-022-02042-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-022-02042-x

Keywords

Navigation